BCLAF1 and hepatocellular carcinoma: In addition, ginsenoside CK significantly inhibited the binding of Bclaf1 and HIF-1α, thereby suppressing HIF-1α-mediated glycolysis in anoxic human hepatoma cells and inhibiting their proliferation (Zhang et al., 2020).